Norcliffe Capital
Investor profile
Venture capital
Deals
3
distinct rounds
Companies
3
backed
Active span
2023–2025
3 yrs
Total round €
€23M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Dxcover | UK | 1 | €11M |
| Laverock Therapeutics | UK | 1 | €7.6M |
| Glen Clova Scientific | UK | 1 | €4.7M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Dxcover | Series A | €11M | 2023-02 |
| Laverock Therapeutics | Seed | €7.6M | 2025-06 |
| Glen Clova Scientific | Seed | €4.7M | 2024-04 |